These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19625039)

  • 1. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917.
    Cimen HI; Serefoglu EC; Balbay MD
    J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy: R. H. Breau, P. L. Crispen, R. E. Jimenez, C. M. Lohse, M. L. Blute and B. C. Leibovich J Urol 2010; 183: 903-908.
    Cimen HI; Canda AE; Balbay MD
    J Urol; 2010 Nov; 184(5):2212; author reply 2212-3. PubMed ID: 20864129
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: histological subtype is an independent predictor of outcome for patients with renal cell carcinoma: B. C. Leibovich, C. M. Lohse, P. L. Crispen, S. A. Boorjian, R. H. Thompson, M. L. Blute and J. C. Cheville J Urol 2010; 183: 1309–1316.
    Dogan B; Canda AE; Akbulut Z; Balbay MD
    J Urol; 2010 Nov; 184(5):2211; author reply 2211-2. PubMed ID: 20884030
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy R. H. Thompson, S. A. Boorjian, C. M. Lohse, B. C. Leibovich, E. D. Kwon, J. C. Cheville and M. L. Blute J Urol 2008; 179: 468-473.
    Bhandari M; Siva S
    J Urol; 2008 Oct; 180(4):1568-9; author reply 1569. PubMed ID: 18718608
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Steiner T, Knels R, Schubert J. Prognostic significance of tumor size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46;2004:327-30.
    Bogdanovic J
    Eur Urol; 2005 Feb; 47(2):266-7. PubMed ID: 15661427
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study: R. H. Thompson, I. Frank, C. M. Lohse, I. R. Saad, A. Fergany, H. Zincke, B. C. Leibovich, M. L. Blute and A. C. Novick. J Urol 2007; 177: 471-476.
    Richstone L; Kavoussi LR
    J Urol; 2007 Sep; 178(3 Pt 1):1119; author reply 1119-20. PubMed ID: 17640684
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Paul L. Crispen, Michael L. Blute. Do percutaneous renal tumor biopsies at initial presentation affect treatment strategies? Eur Urol 2009;55:307-9.
    Park BK
    Eur Urol; 2009 Jun; 55(6):e105-6. PubMed ID: 19297078
    [No Abstract]   [Full Text] [Related]  

  • 8. Rebuttal from authors re: Vincenzo Ficarra, Antonio Galfano and Stefano Cavalleri. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines' recommendations? Eur Urol 2009;55:1315-8.
    Minervini A; Serni S; Di Cristofano C; Carini M
    Eur Urol; 2009 Jun; 55(6):1319-20. PubMed ID: 18804906
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. V. Margulis, P. Tamboli, S. F. Matin, M. Meisner, D. A. Swanson and C. G. Wood. J Urol 2007; 178: 1878-1882.
    Thompson RH; Cheville JC; Leibovich BC; Blute ML
    J Urol; 2008 Jul; 180(1):409; author reply 409-10. PubMed ID: 18495169
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy: D. Y. Yang, R. H. Thompson, H. B. Zaid, C. M. Lohse, A. D. Rule, S. A. Boorjian, B. C. Leibovich, J. C. Cheville and M. K. Tollefson J Urol 2017;198:795-802.
    Gul D; Cimen HI; Gokce A
    J Urol; 2018 Jun; 199(6):1631. PubMed ID: 29555545
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma: T. V. Johnson, A. Abbasi, A. Owen-Smith, A. Young, K. Ogan, J. Pattaras, P. Nieh, F. F. Marshall and V. A. Master J Urol 2010; 183: 480-485.
    Canda AE
    J Urol; 2010 Oct; 184(4):1570-1; author reply 1571. PubMed ID: 20728182
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 14. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
    Simmons MN; Weight CJ; Gill IS
    Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Puppo P, Introini C, Calvi P, Naselli A. Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur Urol 2004;46:477-81.
    Carini M; Lapini A; Minervini A; Serni S
    Eur Urol; 2005 Feb; 47(2):265-6; author reply 266. PubMed ID: 15661426
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment.
    Pomara G; Francesca F
    Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Giannarini G; Autorino R
    Eur Urol; 2010 Jan; 57(1):109-10. PubMed ID: 19062156
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Blute ML
    Eur Urol; 2010 Jan; 57(1):110-1. PubMed ID: 19062158
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal cell carcinoma: vena caval involvement.
    Boorjian SA; Sengupta S; Blute ML
    BJU Int; 2007 May; 99(5 Pt B):1239-44. PubMed ID: 17441917
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinoma and oncocytoma have excellent oncologic outcomes.
    Becker F
    Eur Urol; 2010 Apr; 57(4):666. PubMed ID: 19477584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.